-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$17.5076.23% Upside
Ocular Therapeutix, Inc. Frequently Asked Questions
-
What analysts cover Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. has been rated by research analysts at Robert W. Baird, Piper Sandler, H.C. Wainwright, JMP Securities in the past 90 days.